Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Clin Pharmacol Ther. 2016 Jun 20;100(3):287–294. doi: 10.1002/cpt.401

FIGURE 2. On-treatment platelet reactivity based on B4GALT2 c.909C>T (rs1061781) carrier status [non-carriers versus carriers (hetero- or homozygous)].

FIGURE 2

Platelet reactivity was measured in the discovery cohort by both the (A) VN-P2Y12 and (B) LTA assays. The VN-P2Y12 and LTA results are reported as P2Y12 reaction units (PRU) values and residual platelet aggregation (RPA), respectively.